Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 28, 2011

View Archived Issues

Zoonotic paramyxovirus-neutralizing antibody evaluated in nonhuman primates

Promising preclinical data disclosed on new antiobesity therapy

New exportin-1 inhibitors show preclinical potential in MCL and MM

Scientists reveal new potential use for sitagliptin in cord blood transplant

Clinical data reported on PR-104 in leukemia

Intellikine patents new protein kinase inhibitors

Novel guanylyl cyclase activators prepared by Bayer Schering Pharma

Targacept synthesizes novel nicotinic acetylcholine receptor ligands

New metabotropic glutamate mGlu5 receptor positive allosteric modulators reported

FDA grants new approval for Isentress

Novel antibacterial agents designed in Japan

ThromboGenics submits BLA for ocriplasmin

AVEO Pharmaceuticals begins enrollment in tivozanib trial

Roche submits MAA for vismodegib

Japan Tobacco and Gilead Sciences enter licensing agreement

FDA advisory committee sets Qnexa NDA review date

New European approval for Avastin

Repros Therapeutics reports phase IIb data on Androxal

Karo Bio and Pfizer to jointly develop new drugs for autoimmune diseases

Xenome raises funds for development of peptide pain therapy

Ventrus BioSciences completes enrollment in phase III diltiazem trial

ProteoTech and GSK enter agreement

Researchers begin first clinical study of new HIV vaccine

DV-1179 enters proof-of-mechanism trial

Zogenix completes pre-NDA meetings with FDA for Zohydro

Promising phase III data reported on therapy for opioid-induced constipation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.